DF/BWCC 2020 Collaborative Symposium
Description
The course is designed to give medical oncologists, radiation oncologists, midlevel providers (e.g. nurse practitioners and physician assistants) and nurses, updated information regarding the management of a broad spectrum of cancer types. The Dana-Farber/Brigham and Women’s Cancer Center (DFBWCC) has a robust faculty of sub-specialized medical and radiation oncologists who possess the most up-to-date expertise, best practices, research, and findings on virtually all cancer types. For this activity, subspecialists from the DFBWCC will discuss specifically: 1) Hypersensitivity Identification, Treatment and Workflow 2) New Approaches in Palliative Radiotherapy 3) Team Building and Collaboration
Target Audience
This activity is intended for the Dana-Farber Cancer Care Collaborative (The Collaborative). This includes clinical staff (physicians, nurses, mid-level practitioners) at the cancer centers throughout New England. These sites include: Berkshire Medical Center in Pittsfield, MA; Cape Cod Hospital in Hyannis, MA; UMass Memorial Hospital in Worcester, MA; New England Cancer Specialists in Scarborough, ME; Northern Light Health EMMC in Bangor, ME; Stamford Hospital in Stamford CT.
Learning Objectives
Upon completion of this activity, attendees will be able to:
- Recognize and subsequently mitigate potential risk associated with medication related infusion reactions by adopting an updated hypersensitivity reaction algorithm and clinical workflow as outlined and demonstrated by DFCI/BWH.
- Apply knowledge of advances in palliative radiotherapy to the care of patients with cancer.
- Evaluate their current teams and adopt recommendations outlined in the presentation in order to improve their teams’ efficacy and promote a more productive and collaborative workgroup.
Additional Information
The Dana-Farber Cancer Care Collaborative & Mass General Brigham
1:00pm | Team Building and Collaboration Craig Bunnell, MD Anne Gross, PhD, RN, NEA-BC |
2:00 | Break |
2:10 | Hypersensitivity Identification, Treatment and Workflow Mariana Castells, MD, PhD Donna-Marie Lynch, NP Bridget Scullion, PharmD |
3:10 | Break |
3:20 | New Approaches in Palliative Radiotherapy Tracy A. Balboni, MD, MPH |
4:20pm | Adjourn |
Course Director
Rachel Freedman, MD, MPH
Medical Director, DFCI Cancer Care Collaborative,
Senior Physician, Dana-Farber Cancer Institute;
Associate Professor of Medicine, Harvard Medical School
Speakers
Tracy A. Balboni, MD, MPH
Clinical Director, Supportive and Palliative Radiation Oncology Service,
Dana-Farber/Brigham and Women's Cancer Center
Craig Bunnell, MD
Chief Medical Officer, Dana-Farber Cancer Institute
Mariana Castells, MD, PhD
Director, Drug Hypersensitivity and Desensitization Center,
Director Mastocytosis Center,
Brigham and Women's Hospital
Anne Gross, PhD, RN, NEA-BC
Senior Vice President, Patient Care Services and Chief Nursing Officer,
Dana-Farber Cancer Institute
Donna-Marie Lynch, NP
Department of Medicine, Rheumatology, Immunology,
Brigham and Women's Hospital,
Bridget Scullion PharmD, BCOP
Clinical Pharmacy Manager,
Department of Pharmacy,
Dana-Farber Cancer Institute
Accreditation
Mass General Brigham is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mass General Brigham designates this live activity for a maximum of 3 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Dana-Farber Cancer Institute is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Up to 3.00 Contact Hours of Nursing Continuing Professional Development (NCPD) will be awarded for attending the sessions and completing evaluations. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 3.00 AMA PRA Category 1 Credit™
- 3.00 Nursing Contact Hours
- 3.00 Participation